Objective: To report intractable life-threatening pulmonary hemorrhage after cardiac surgery in an infant who was treated successfully with recombinant activated factor VII (rFVIIa).
Design: Descriptive case report.
Setting: An 18-bed pediatric intensive care unit at a tertiary-care children's hospital.